Summary
Name | cyclosporin A |
Synonyms | (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl) (ChEBI), 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine] (JCBN), 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone (ChEBI), Antibiotic S 7481F1 (ChemIDplus), ciclosporin (KEGG DRUG), Ciclosporin (KEGG COMPOUND), ciclosporina (ChemIDplus), ciclosporine (ChemIDplus), ciclosporinum (ChemIDplus), Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl) (ChemIDplus), Cyclosporin A (KEGG COMPOUND), Cyclosporine (KEGG COMPOUND), Cyclosporine (ChemIDplus), Gengraf (DrugBank), Neoral (DrugBank), Sandimmune (DrugBank) |
IUPAC | 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
Formula | C62H111N11O12 |
PRIMARY ID (Read more) |
CHEBI:4031 |
Type | chemical |
Relations | 7 |
Pathways | Focal segmental glomerulosclerosis, Satellite: Calcium&myogenesis |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Relations
Regulator | Mechanism | target | score ℹ | |
---|---|---|---|---|
+ | cyclosporin A | down-regulates chemical inhibition | PPP3CC | 0.8 |
Publications: | 1 | Organism: | Homo Sapiens | |
+ | cyclosporin A | down-regulates chemical inhibition | PP2B | 0.8 |
Publications: | 1 | Organism: | Homo Sapiens | |
+ | cyclosporin A | up-regulates | TTN | 0.8 |
Publications: | 1 | Organism: | Homo Sapiens | |
+ | cyclosporin A | down-regulates chemical inhibition | PPP3CB | 0.8 |
Publications: | 1 | Organism: | Homo Sapiens | |
+ | cyclosporin A | down-regulates chemical inhibition | PPP3CA | 0.8 |
Publications: | 1 | Organism: | Homo Sapiens | |
+ | cyclosporin A | down-regulates chemical inhibition | Calcineurin | 0.8 |
Publications: | 2 | Organism: | Rattus Norvegicus, Homo Sapiens | |
Tissue: | Skeletal Muscle | |||
Pathways: | Focal segmental glomerulosclerosis |